Cervicocerebral atherosclerosis and atrial fibrillation increase long-term mortality in patients with ischemic stroke

Kati Lainelehto1, Juha-Pekka Pienimäki2, Sirpa Savilahti2

  • 1Emergency Department Acuta, Tampere University Hospital, Wellbeing services of Pirkanmaa, PL 2000, 33521 Tampere, Finland.

Insights

Atrial fibrillation (AF) and brain artery atherosclerosis increase stroke risk. Concurrent AF and high atherosclerotic burden significantly elevate long-term mortality in stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Atrial fibrillation (AF) and cerebrovascular atherosclerosis are key risk factors for ischemic events.
  • The combined impact of AF and atherosclerosis on long-term mortality after acute ischemic stroke or TIA remains understudied.

Purpose of the Study:

  • To investigate the association between concurrent atrial fibrillation (AF) and cervicocerebral atherosclerotic burden (CAB) with long-term mortality in patients with acute ischemic stroke or TIA.
  • To quantify the independent and combined effects of AF and CAB on mortality risk.

Main Methods:

  • 406 patients with acute ischemic stroke or TIA underwent computed tomography angiography (CTA) to assess cervicocerebral arteries.
  • Cervicocerebral Atherosclerotic Burden (CAB) score was calculated, and patients were analyzed based on AF status and CAB score quartiles.

Main Results:

  • Long-term follow-up (median 7.3 years) revealed significantly higher mortality in patients with AF (52.0%) compared to those without AF (27.0%).
  • In AF patients, the two highest CAB score quartiles were independently associated with increased mortality (HRs 12.7 and 15.8).
  • A combined analysis showed a 3-fold increased mortality risk in AF patients with high CAB scores compared to those without AF and low CAB scores.

Conclusions:

  • Elevated atherosclerotic burden in brain-supplying arteries is a significant independent predictor of long-term mortality in patients with acute ischemic stroke or TIA and concurrent AF.
  • The combination of AF and substantial cervicocerebral atherosclerosis poses a particularly high mortality risk.
Abstract

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
346
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
434
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
306
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
795